title: Prenatal methadone exposure and neonatal neurobehavioral functioning.
abstract: Opioid-exposed infants display a wide and variable range of dysregulated neurobehavioral functioning, but the regulatory difficulties experienced by these infants outside the defined clusters of neonatal abstinence syndrome (NAS) have not been well described and may have implications for the infant's developmental course. This study describes the neurobehavioral functioning of neonates prenatally exposed to methadone, using the NICU Network Neurobehavioral Scale (NNNS), and explores the relationships between maternal factors and infant functioning. The relationship between NNNS measures, NAS severity, and need for pharmacotherapy for NAS was also evaluated. Infants who required pharmacologic treatment for NAS showed more dysregulated behavior and signs of stress and abstinence as indicated by NNNS scores, but NNNS scores were not significantly correlated with maternal methadone dose. The determination of the range of the methadone-exposed infant's neurobehavioral repertoire could guide the optimal treatment of all such infants, particularly those requiring only nonpharmacologic care.
authors.affiliation: Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.
authors.forename: Martha L
authors.initials: ML
authors.lastname: Velez
authors.forename: Lauren M
authors.initials: LM
authors.lastname: Jansson
authors.forename: Jennifer
authors.initials: J
authors.lastname: Schroeder
authors.forename: Erica
authors.initials: E
authors.lastname: Williams
mesh_terms: D000704:Analysis of Variance; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D053609:Lethargy / Q000139:chemically induced; D018811:Maternal Exposure; D008691:Methadone / Q000009:adverse effects*; D009068:Movement / Q000187:drug effects; D009122:Muscle Hypertonia / Q000139:chemically induced; D009123:Muscle Hypotonia / Q000139:chemically induced; D009357:Neonatal Abstinence Syndrome / Q000473:pathology*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000503:physiopathology*; D012021:Reflex, Abnormal / Q000187:drug effects; D013312:Stress, Physiological / Q000187:drug effects
chemical_list: D008691:Methadone
references.citation: Drug Alcohol Depend. 2004 Sep 6;75(3):253-60
references.pmid: 15283946
references.citation: Int J Neuropsychopharmacol. 2003 Sep;6(3):253-65
references.pmid: 12974992
references.citation: J Opioid Manag. 2009 Jan-Feb;5(1):47-55
references.pmid: 19344048
references.citation: Neurol Clin. 2000 Aug;18(3):541-62
references.pmid: 10873230
references.citation: Pediatrics. 1996 Jul;98(1):71-5
references.pmid: 8668415
references.citation: Neurotoxicol Teratol. 2008 Jan-Feb;30(1):20-8
references.pmid: 18031987
references.citation: J Epidemiol Community Health. 2001 Sep;55(9):687-8
references.pmid: 11548709
references.citation: J Matern Fetal Neonatal Med. 2007 Sep;20(9):677-85
references.pmid: 17701668
references.citation: J Pediatr. 2006 Dec;149(6):781-7
references.pmid: 17137892
references.citation: BJOG. 2009 Apr;116(5):665-71
references.pmid: 19220239
references.citation: Pediatrics. 1974 Nov;54(5):583-6
references.pmid: 4453456
references.citation: Harm Reduct J. 2008 Feb 06;5:6
references.pmid: 18254953
references.citation: Arch Dis Child Fetal Neonatal Ed. 2005 Jan;90(1):F73-4
references.pmid: 15613582
references.citation: J Addict Dis. 1993;12(4):45-57
references.pmid: 8292639
references.citation: J Addict Med. 2008 Sep;2(3):113-20
references.pmid: 19727440
references.citation: Pediatrics. 2002 Dec;110(6):1182-92
references.pmid: 12456917
references.citation: Addict Dis. 1975;2(1-2):141-58
references.pmid: 1163358
references.citation: J Subst Abuse Treat. 1996 Jul-Aug;13(4):321-9
references.pmid: 9076650
references.citation: Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):606-10
references.pmid: 16150249
references.citation: Pediatrics. 1982 Aug;70(2):210-3
references.pmid: 7099786
references.citation: Ann N Y Acad Sci. 1998 Jun 21;846:296-305
references.pmid: 9668416
references.citation: Pediatrics. 1998 Jun;101(6):1079-88
references.pmid: 9614425
references.citation: Am J Obstet Gynecol. 2003 Aug;189(2):312-7
references.pmid: 14520184
references.citation: Pediatr Pharmacol (New York). 1982;2(2):113-20
references.pmid: 12760403
references.citation: Pediatrics. 2008 Jan;121(1):106-14
references.pmid: 18166563
references.citation: Pediatrics. 2004 Mar;113(3 Pt 2):676-8
references.pmid: 14993526
references.citation: J Subst Abuse Treat. 1992;9(3):199-213
references.pmid: 1334156
references.citation: Pediatrics. 2003 Jun;111(6 Pt 1):1318-23
references.pmid: 12777547
references.citation: Am J Orthopsychiatry. 1993 Apr;63(2):266-76
references.pmid: 7683453
references.citation: Pediatrics. 2004 Mar;113(3 Pt 2):641-67
references.pmid: 14993524
references.citation: Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):611-7
references.pmid: 16150250
references.citation: Neurotoxicol Teratol. 1997 Jul-Aug;19(4):295-303
references.pmid: 9253008